Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

GLOBAL MARKETS-Record-high stocks bask in November reign

Published 2020-11-17, 08:07 a/m
Updated 2020-11-17, 08:12 a/m
© Reuters.

* World stocks at record high on vaccine optimism

* Oil adds to 16% November surge

* Dollar weakens on rising case numbers, yuan rising

* Graphic: 2020 asset performance http://tmsnrt.rs/2yaDPgn

* Graphic: World FX rates in 2020 http://tmsnrt.rs/2egbfVh

*

By Marc Jones

LONDON, Nov 17 (Reuters) - World stock markets grabbed a well-earned breather on Tuesday after a second major coronavirus vaccine boost in the space of a week had propelled them higher again and put Europe on course for its best month nearly three decades.

The pan-European STOXX 600 dipped 0.4% .STOXX on the day with Wall Street set to follow, but there was little sign of an end to the November bull run that has also seen confidence-sensitive commodities and emerging markets surge. .EU EMRG/FRX O/R

MSCI's main 49-country world stocks index was perched at a record high having risen 11% and every day but one this month, while China's yuan hit a near 2-1/2 year peak in the currency markets as the U.S. dollar continued to sag. /FRX are in "full bull" mode, BofA's monthly investor survey showed on Tuesday. global economic growth and profit expectations running at a 20-year high among those the bank surveyed, the "reopening rotation" back into coronavirus-hit sectors is likely to continue for the rest of the year, BofA added, although they did also recommend cashing in in the coming weeks or months.

The latest boost had come from Moderna MRNA.O , which said on Monday its experimental COVID-19 vaccine was 94.5% effective in preventing infection based on interim late-stage data.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The U.S.-based firm became the second drugmaker, after Pfizer (NYSE:PFE) PFE.N , to announce promising data. The news had sent its shares up nearly 10%, though it was electric car maker Tesla TLSA.O in the fast lane on Tuesday, racing up 11% in premarket moves after it won a spot in the S&P 500. .N about 450% in 2020, the California firm has become the most valuable auto company in the world, by far, despite production that is a fraction of rivals such as Toyota 7203.T , Volkswagen VOWG_p.DE and General Motors (NYSE:GM) GM.N .

MSCI's broadest index of Asia-Pacific shares outside Japan .MIAPJ0000PUS gained 0.2% overnight, a day after hitting its highest level since launching in 1987. .T .SS

Japan's Nikkei 225 .N225 rose 0.4% after hitting a 29-year high the day before, but Chinese blue chips .CSI300 dipped as recent bond defaults hit sentiment. market is assuming that we can see the end of the tunnel, that in 2022 a large part of the world's population will start to receive access to vaccines," said Herald van der Linde, HSBC's head of equity strategy for Asia Pacific.

There were initial indications that this was sparking a change in investors' attitudes, he added.

CHINA AND BULLS

The positive vaccine news helped oil prices add to their 16% November gains.

U.S. crude CLc1 inched up to $41.57 per barrel after rising 3.02% on Monday, and Brent LCOc1 gained 0.7% after a 2.43% jump the day before. currency markets, China's central bank on Tuesday lifted its official yuan midpoint to the highest in nearly 29 months, underpinned by solid gains in spot prices a day earlier on the back of strong economic data. authorities are making a lot of effort to prevent the yuan from rising too fast," said a trader at a Chinese bank. vaccine news also helped the risk-friendly Australian dollar AUD=D4 , which climbed to a one-week high against its U.S. counterpart. Rising virus case numbers in the United States clouded views on the dollar, adding to the 10.5% drop it has seen against a basket of major currencies since March =USD . zone bond markets showed little reaction to Hungary and Poland's veto of the EU's budget and recovery fund in early Tuesday trade.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Italy was expected to sell a U.S. dollar bond while China was preparing for a potentially record euro-denominated bond sale which was due to be finalised on Wednesday.

Euro zone bonds, which sold off moderately and then recouped losses later on Monday, were steady in early Tuesday trade, with Germany's 10-year benchmark yield at -0.55% DE10YT=RR and Italy's 10-year yield at 0.61%. IT10YT=RR

The closely watched gap between Italian and German 10-year yields - effectively the risk premium on debt from Italy, one of the main beneficiaries of the recovery fund - was near its lowest since early 2018 at around 115 basis points.

The lack of market reactions "tend to reflect the market's view that the EU will find a way to hammer out a compromise that keeps all parties roughly happy," Andy Cossor, a strategist at DZ Bank, said of the Polish and Hungarian vetoes.

<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ Global assets

http://tmsnrt.rs/2jvdmXl Global currencies vs. dollar

http://tmsnrt.rs/2egbfVh Emerging markets

http://tmsnrt.rs/2ihRugV MSCI All Country Wolrd Index Market Cap

http://tmsnrt.rs/2EmTD6j China's Yuan is surging

https://tmsnrt.rs/3pECkSL

^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.